UPDATE: Athenahealth (ATHN) Tops Q3 EPS by 8c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
athenahealth (ATHN) PT Lowered to $142 at KeyBanc Following 3Q
November 12, 2018 7:52 AM ESTKeyBanc analyst Donald Hooker lowered the price target on athenahealth (NASDAQ: ATHN) to $142.00 (from $170.00) while maintaining a Overweight rating following the company's 3Q. ATHN reported weak 3Q18 top-line metrics with soft bookings of only $38M (down ~34% y/y) and revenues lagging consensus ($330M vs.... More
Baird Downgrades athenahealth (ATHN) to Neutral Following Takeout Bid
November 12, 2018 4:21 AM ESTBaird analyst Matthew Gillmor downgraded athenahealth (NASDAQ: ATHN) from Outperform to Neutral with a price target of $135.00 (from $160.00).
The analyst steps aside following the expected takeout from Veritas and Elliot. He is not expecting a competing bid to emerge.
For an analyst... More
